Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High-Grade Meningiomas

被引：6

作者：

Peetz-Dienhart, Susanne ^{[1
]}

Spille, Dorothee Caecilia ^{[2
]}

Sporns, Peter B. ^{[3
]}

Adeli, Alborz ^{[3
]}

Bunk, Eva Christine ^{[2
]}

Wagner, Andrea ^{[1
]}

Paulus, Werner ^{[1
]}

Stummer, Walter ^{[2
]}

Hess, Katharina ^{[1
]}

Brokinkel, Benjamin ^{[2
]}

机构：

[1] Univ Hosp Munster North Rhine Westphalia, Inst Neuropathol, Munster, Germany

[2] Univ Hosp Munster North Rhine Westphalia, Dept Neurosurg, Munster, Germany

[3] Univ Hosp Munster North Rhine Westphalia, Inst Clin Radiol, Munster, Germany

来源：

NEUROSURGERY | 2020年 / 86卷 / 03期

关键词：

D O I：

10.1093/neuros/nyz474

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：E362 / E365

页数：4

共 50 条

[21] Radiomics Features Predict Telomerase Reverse Transcriptase Promoter Mutations in World Health Organization Grade II Gliomas via a Machine-Learning Approach
Fang, Shengyu
Fan, Ziwen
Sun, Zhiyan
Li, Yiming
Liu, Xing
Liang, Yuchao
Liu, Yukun
Zhou, Chunyao
Zhu, Qiang
Zhang, Hong
Li, Tianshi
Li, Shaowu
Jiang, Tao
Wang, Yinyan
Wang, Lei
FRONTIERS IN ONCOLOGY, 2021, 10
[22] High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions (vol 4, 2218, 2013)
Nault, Jean Charles
Mallet, Maxime
Pilati, Camilla
Calderaro, Julien
Bioulac-Sage, Paulette
Laurent, Christophe
Laurent, Alexis
Cherqui, Daniel
Balabaud, Charles
Zucman-Rossi, Jessica
NATURE COMMUNICATIONS, 2013, 4
[23] In vitro Tumor-targeted radionuclide Therapy using the human sodium-iodide symporter driven by telomerase reverse transcriptase promoter
Liu, Z. L.
Shi, Y. Z.
Huang, H.
Tang, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S472 - S472
[24] Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency
Jiang, Hui
Guo, Song
Xiao, Dan
Bian, Xuzhao
Wang, Jie
Wang, Ying
Zhou, Huiting
Cai, Jun
Zheng, Zhongliang
ONCOTARGET, 2017, 8 (23) : 37694 - 37704
[25] Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival
Yoo, Hyunwoo
Kim, Hyun-Soo
CANCER GENOMICS & PROTEOMICS, 2023, 20 (06) : 626 - 636
[26] Therapy of murine bladder cancer with tumor-specific suicide gene expression driven by human telomerase reverse transcriptase promoter in syngeneic mouse tumor model
Shieh, GS
JOURNAL OF UROLOGY, 2003, 169 (04): : 188 - 188
[27] Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter
Jacob, D
Davis, J
Zhu, HB
Zhang, LD
Teraishi, F
Wu, SH
Marini, FC
Fang, BL
CLINICAL CANCER RESEARCH, 2004, 10 (10) : 3535 - 3541
[28] Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter
Kim, Seung Hoo
Chung, Hye Kyung
Kang, Joo Hyun
Kim, Kwang Il
Jeon, Yong Hyun
Jin, Yong Nan
Yun, Chae Ok
Chung, June-Key
HUMAN GENE THERAPY, 2008, 19 (09) : 951 - 957
[29] Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers
Gu, J
Kagawa, S
Takakura, M
Kyo, S
Inoue, M
Roth, JA
Fang, BL
CANCER RESEARCH, 2000, 60 (19) : 5359 - 5364
[30] Diffusion-weighted MRI precisely predicts telomerase reverse transcriptase promoter mutation status in World Health Organization grade IV gliomas using a residual convolutional neural network
Hu, Congman
Fang, Ke
Du, Quan
Chen, Jiarui
Wang, Lin
Zhang, Jianmin
Bai, Ruiliang
Wang, Yongjie
BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1163): : 1806 - 1815

← 1 2 3 4 5 →